fda warning letters compounding semaglutide news issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Issues Warning Letters to

The surgery can be performed using different methods, such as liposuction, direct excision of the tissue or a combination thereof, depending on each unique case

Importantly, GLP-1 only triggers insulin when blood sugar is high, which reduces the risk of hypoglycemia (dangerously low blood sugar)

For reference, retatrutide titration in these trials followed a slow ramp over 2436 weeks: Weeks 14: 2mg/week Weeks 58: 4mg/week Weeks 912: 8mg/week Week 13+: 12mg/week (for 12mg group) The slow titration is important GI tolerability at higher doses improves significantly with gradual escalation

Detailed Results 1 From January 1, 2022, to June 30, 2025, GLP-1 exposure was defined as first prescription prior to the breast imaging examination with documented outcome from the imaging

While Ozempic is approved to help slow kidney disease progression, there have been reports of acute (sudden) kidney injury and worsening of CKD with Ozempic since the drug was made available on the market

What Are the Side Effects of Subcutaneous Injections